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Abstract
Background: Advanced glycation end products (AGE) alter lipid metabolism and reduce the macrophage expression
of ABCA-1 and ABCG-1 which impairs the reverse cholesterol transport, a system that drives cholesterol from arterial
wall macrophages to the liver, allowing its excretion into the bile and feces. Oxysterols favors lipid homeostasis in
macrophages and drive the reverse cholesterol transport, although the accumulation of 7-ketocholesterol, 7alpha-
hydroxycholesterol and 7beta- hydroxycholesterol is related to atherogenesis and cell death. We evaluated the effect
of glycolaldehyde treatment (GAD; oxoaldehyde that induces a fast formation of intracellular AGE) in macrophages
overloaded with oxidized LDL and incubated with HDL alone or HDL plus LXR agonist (T0901317) in: 1) the
intracellular content of oxysterols and total sterols and 2) the contents of ABCA-1 and ABCG-1.
Methods: Total cholesterol and oxysterol subspecies were determined by gas chromatography/mass spectrometry
and HDL receptors content by immunoblot.
Results: In control macrophages (C), incubation with HDL or HDL + T0901317 reduced the intracellular content of
total sterols (total cholesterol + oxysterols), cholesterol and 7-ketocholesterol, which was not observed in GAD
macrophages. In all experimental conditions no changes were found in the intracellular content of other oxysterol
subspecies comparing C and GAD macrophages. GAD macrophages presented a 45% reduction in ABCA-1 protein
level as compared to C cells, even after the addition of HDL or HDL + T0901317. The content of ABCG-1 was
36.6% reduced in GAD macrophages in the presence of HDL as compared to C macrophages.
Conclusion: In macrophages overloaded with oxidized LDL, glycolaldehyde treatment reduces the HDL-mediated
cholesterol and 7-ketocholesterol efflux which is ascribed to the reduction in ABCA-1 and ABCG-1 protein level.
This may contribute to atherosclerosis in diabetes mellitus.
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Background
Oxysterols are oxidized derivatives of cholesterol that act
as important mediators of lipid metabolism, particularly
by driving intracellular lipid homeostasis and the reverse
cholesterol transport [1,2]. Nonetheless, the accumula-
tion of 7-ketocholesterol, 7alpha-hydroxycholesterol and
7beta-hydroxycholesterol has been implicated in the
development of atherosclerosis as wells as inflammation
and macrophage foam cell death [3].
In diabetes mellitus, advanced glycation end products
(AGE) impair lipid metabolism and reverse cholesterol
transport by diminishing the expression of ABCA-1,
ABCG-1 and the activity of lecithin cholesterol acyltrans-
ferase [4-6]. On the hand, glycation enhances cholesteryl
ester transfer protein activity making more cholesterol
available for arterial wall macrophage by the uptake of
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data available on the role played by intracellular advanced
glycation elicited by the treatment with oxoaldehydes -
that induce a rapid formation of AGE - in the intracellu-
lar content of oxysterols subspecies. Then the aim of this
study was to analyze in oxidized LDL-overloaded macro-
phages treated with HDL alone or HDL plus LXR agonist
(T0901317) the effect of advanced glycation in the selec-
tive distribution of oxysterols and the total content of
sterols as well as the expression of ABCA-1 and ABGC-1.
Methods
Lipoprotein isolation and oxidative modification
Low density lipoprotein (LDL; d = 1.019-1.063 g/mL) and
high density lipoprotein (HDL; d = 1.063-1.121 g/mL)
were isolated after sequential preparative ultracentrifuga-
tion of fresh plasma drawn from healthy donors and
were purified by discontinuous gradient ultracentrifuga-
tion. After dialysis, all lipoproteins fractions were steri-
lized in a 0.22 μm filter. LDL was oxidized according to
Steinbrecher et al. [8] and protein was measured by the
Lowry technique [9]
Cell Culture and Experimental Protocol
J774 macrophages were cultured in RPMI 1640 medium
( G i b c o ,G r a n dI s l a n d ,N e wY o r k ,U S A )c o n t a i n i n g1 0 %
fetal calf serum (Cultilab, Campinas, Brazil), penicillin and
streptomycin (Gibco), and maintained in a 5% CO2 incu-
bator at 37°C. After reaching confluence, macrophages
were enriched with oxidized LDL (50 μg/mL of low glu-
cose DMEM - Gibco) for 48h and then treated with
0.5 mM glycolaldehyde (Sigma Chem. Com. St. Louis,
USA) (GAD-macrophages) or DMEM alone (C-macro-
phages) for the last 5h, in the absence or presence of the
LXR-agonist, T0901317 (1 μM). Cells were carefully
washed and incubated with 50 μg/mL of HDL (5 h) in the
absence or presence of T0901317.
Oxysterols and total cholesterol determination
Sterol standards (cholesterol, 7alpha-hydroxycholesterol,
7beta-hydroxycholesterol, 7-ketocholesterol, colestan-
3beta, 5alpha, 6beta-triol, 5alpha, 6alpha-epoxycholesterol,
5beta, 6beta-epoxycholesterol, 24(s), 25 epoxycholesterol,
25-hydroxycholesterol and 27-hydroxycholesterol), includ-
ing internal standard 5beta-cholestane, were obtained
from Steraloids Inc. (Wilton, NH, USA).
Cellular lipids were extracted with hexane:isopropanol
(3:2, v/v). To the lipid extract it was added 10 μgo f
5alpha-cholestane (internal standard) following evapora-
tion under nitrogen. Samples were redissolved in 1.0 mL
toluene/ethyl acetate (1 : 1, v/v) and applied to diol extrac-
tion columns (Waters Corporation, Ireland), previously
conditioned with the same solvent. After collection of the
first eluent fraction under mild vacuum, columns were
eluted with 2.0 mL of toluene/ethyl acetate and the eluent
was pooled with the original fraction. The toluene/ethyl
acetate fraction was evaporated to dryness under nitrogen,
and redissolved in 2.0 mL diethyl ether and subjected to a
two-phase alkaline saponification procedure. The recov-
ered ether phase was dryness under nitrogen and deriva-
tized after additions of 100 μL pyridine (Merck, Rio de
Janeiro, Brazil) and N,O-bis(trimethylsylil) trifluoroaceta-
mide (BSTFA; Supelco - Bellefonte, USA). Vials were
sealed, purged with nitrogen, and heated to 60°C for
60 min [10]. Samples were transferred to tubes with ether,
followed by gas chromatography-Mass Spectrometer
detection (GC-MS) analysis. One μLa l i q u o tw a st h e n
injected into a QP 2010 plus (Shimadzu - Kyoto, Japan)
gas chromatograph equipped with Rxi-1ms de 30 m
(Restec - Bellefonte, EUA) and Mass Spectrometer detec-
tor. Helium was used as the carrier gas at a flow rate of
5 mL/min; the injection temperature was set at 290°C and
the initial column temperature at 240°C, with a split ratio
of 1:5. The ion detector temperature was set at 300°C and
a programmed temperature run was used with the initial
temperature held for 1 min followed by a 5°C/min tem-
perature ramp to 290°C, with the final temperature held
for 20 min [10].
Immunoblot
J774 Macrophages were scraped into Tris buffer saline
containing protease inhibitors. Equal amounts of cell
protein were applied to a 6% polyacrylamide gel (SDS-
PAGE) and blotted to Amersham Hybond ECL Nitrocel-
lulose Membrane (GE healthcare, Little Chalfont, UK).
The blots were treated with defatted dry milk (5%) in
PBS/0.05% Tween 20, and incubated for 3h with pri-
mary antibodies, anti ABCA-1 or anti ABCG-1, 1:1000
(Novus Biologicals, Inc., Littleton, USA) in blocking buf-
fer. After washing three times with TBS/0.05% Tween
20, membranes were incubated with peroxidase-conju-
gated anti-mouse or anti-rabbit antibodies (GE health-
care) for 2 h, washed and developed with a SuperSignal
West Pico Chemiluminescent Substrate (Termo Scienti-
fic Rockford, IL, EUA). Chemiluminescence was
detected by ImageQuant 350 (GE Healthcare, Piscata
Way, NJ, USA). Data are presented as arbitrary units
corrected per beta-actin 1: 1000 (Fitzgerald industries
int., Acton, MA, USA).
Statistical analysis
Statistical analyses were performed using GraphPad
Prism 4.0 software (GraphPad Prism, Inc., San Diego,
CA). Student’s T test was utilized to compare results
(mean ± SD). One way ANOVA and Bonferroni post
test (mean ± SD) was utilized to compare results among
groups. A p-value < 0.05 was considered statistically
significant.
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The content of oxysterols and total cholesterol in oxi-
dized LDL and native HDL utilized in cell incubations is
shown in Table 1. In oxidized LDL the amount of
oxysterols was superior to cholesterol as expected by the
chemical modification induced in vitro. Also, the higher
amount of oxysterols was represented by 7-ketocholes-
terol (40.9%), 7beta-hydroxycholesterol (21.3%), 7alpha-
hydroxycholesterol (20.5%) and cholesterol-5,6beta
(9.1%). In HDL we only observed a very small amount
of oxysterols.
In control macrophages the presence of HDL or HDL +
T0901317 reduced, respectively, 16% and 22% the
amount of intracellular total sterols (oxysterols + choles-
terol) in comparison to cells maintained in the presence
of culture medium alone. No differences were found in
the amount of total sterols when comparing control
macrophages treated with HDL and HDL + T0901317
(Figure 1). In opposition, in GAD macrophages the addi-
tion of HDL or HDL + T0901317 was not able to reduce
intracellular content of total sterols (Figure 1).
Intracellular cholesterol content was also reduced in
control macrophages after incubation with HDL (17%) or
HDL + T0901317 (22%) which was not observed in
GAD-macrophages (Figure 2). In addition, in control
macrophages, HDL and HDL + T0901317, respectively
diminished, 16% e 21% the intracellular content of
7-ketocholesterol, without affecting other oxysterols. On
the other hand, 7-ketocholesterol was not reduced in
GAD-macrophages after incubation with HDL or HDL +
T0901317 (Figure 3 and Table 2).
In oxidized LDL overloaded control and GAD-macro-
phages the ABCA-1 protein level was, respectively, 2.8
and 1.8 times enhanced in comparison to non-over-
loaded cells (data not shown). In the presence of HDL
or HDL + T0901317, control macrophages presented a
2.9 and 2.4 fold enhancement in ABCA-1 content, in
comparison to cells maintained in culture medium alone
(Figure 4). In comparison to C, GAD-macrophages pre-
sented a smaller amount of ABCA-1 (45%) with no
increment in protein level attained after incubation with
HDL or HDL + T0901317 (Figure 4).
ABCG-1 level was 30% reduced in control macro-
phages treated with oxidized LDL in comparison to
non-overloaded cells. In control macrophages previously
enriched with oxidized LDL, the presence of HDL was
Table 1 Oxysterols and total cholesterol in oxidized LDL
and native HDL (ng/μg of protein ± DP)
LDLox HDL
(n = 5) (n = 2)
7-ketocholesterol 73.1 ± 18 0.96 ± 0.70
7b-hydroxycolesterol 38.1 ± 8 0.64 ± 0.13
7a-hydroxycolesterol 36.6 ± 8 0.38 ± 0.11
cholesterol- 5,6 a 16.16 ± 4 0.17 ± 0.04
cholesterol-5,6 b 12.97 ± 11 0.01 ± 0.02
cholestan-3b,5a,6b-triol 1.321 ± 0.3 0.19 ± 0.01
24.25 epoxycholesterol ND 1.90 ± 0.22
25-hydroxycholesterol 1.06 ± 0.2 0.03 ± 0.01
27-hydroxycholesterol 0.11 ± 0.07 0.02 ± 0.01
Total oxysterols 179.4 ± 39 5.83 ± 2.79
Total cholesterol 99.1 ± 7 93.73 ± 0.89
Figure 1 Total sterols content in control and glycolaldehyde-
treated macrophages. J774 macrophages were overloaded with
oxidized LDL (50 μg/mL de DMEM) for 48 h. In the last 5h, cells
were incubated with 0.25 mM glycolaldehyde (GAD; black bars) and
1 μM LXR agonist (T0901317). Control cells (C; gray bars) were
incubated with T0901317 alone. After washing, macrophages were
incubated for 5 h with HDL alone (50 μg/mL de DMEM) or HDL +
T0901317. Total sterols were determined after lipid cell extraction by
CG/MS, utilizing 5-alpha cholestane as an internal standard.
Figure 2 Total cholesterol content in control and glycolaldehyde-
treated macrophages. J774 macrophages were overloaded with
oxidized LDL (50 μg/mL de DMEM) for 48 h. In the last 5h, cells were
incubated with 0.25 mM glycolaldehyde (GAD; black bars) and 1 μM
LXR agonist (T0901317). Control cells (C; gray bars) were incubated
with T0901317 alone. After washing, macrophages were incubated for
5 h with HDL alone (50 μg/mL de DMEM) or HDL + T0901317. Total
cholesterol was determined after lipid cell extraction by CG/MS,
utilizing 5-alpha cholestane as an internal standard.
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changes by the addition of T0901317 (Figure 5).
As compared to oxidized LDL non-overloaded cells, in
GAD-macrophages, oxidized LDL enrichment did not
change cell content of ABCG-1. In this case, the pre-
sence of HDL diminished 36.6% the amount of ABCG-1
in comparison to control cells treated with this lipopro-
tein. Also, in GAD-macrophages the incubation with
HDL and HDL + T0901317 reduced the protein level of
ABCG-1 as compared to GAD-cells maintained in cul-
ture medium alone (Figure 5).
Discussion
Advanced glycation end products are independently
associated with the development of atherosclerosis [11].
Oxysterols, mainly 24(s),25 epoxycholesterol, 22(R)-
hydroxycholesterol, o 24(S)-hydroxycholesterol and 25
hydroxycholesterol [12], modulate intracellular choles-
terol exportation by increasing the LXR-mediated
expression of ABCA-1 and ABCG-1 [13]. On the other
Figure 3 7-ketocholesterol content in control and glycolaldehyde-
treated macrophages. J774 macrophages were overloaded with
oxidized LDL (50 μg/mL de DMEM) for 48 h. In the last 5h, cells were
incubated with 0.25 mM glycolaldehyde (GAD; black bars) and 1 μM
LXR agonist (T0901317). Control cells (C; gray bars) were incubated with
T0901317 alone. After washing, macrophages were incubated for 5 h
with HDL alone (50 μg/mL de DMEM) or HDL + T0901317. 7-
ketocholesterol was determined after lipid cell extraction by CG/MS,
utilizing 5-alpha cholestane as an internal standard.
Table 2 Oxysterols and total cholesterol in control (C) and glycolaldehyde-treated macrophages (GAD)
Macrophage C GAD
- HDL HDL
+
T0901317
- HDL HDL
+
T0901317
7-ketocholesterol 86.7 ± 16 72.8 ± 14* 68.4 ± 14* 83.8 ± 19 74.2 ± 13 79.8 ± 19
7b-hydroxicholesterol 26.7 ± 9 20.4 ± 6 21.5 ± 10 25.5 ± 10 23.6 ± 6 22.8 ± 10
7a-hydroxicholesterol 9.2 ± 4 8.1 ± 3 8.1 ± 5 9.4 ± 3 8.8 ± 2 8.6 ± 4
cholesterol-5,6 b 22.6 ± 9 20 ± 5 16.9 ± 6 24.2 ± 6 22.9 ± 6 20.5 ± 6
cholesterol- 5,6 a 7.1 ± 2 6.6 ± 2 5.5 ± 2 7.4 ± 2 6.2 ± 2 6.7 ± 3
24.25 epoxycholesterol 3.8 ± 2 3.5 ± 2 2.8 ± 1 3.9 ± 2 3.7 ± 2 3.5 ± 2
27-hydroxycholesterol 0.48 ± 0.2 0.51 ± 0.3 0.44 ± 0.2 0.55 ± 0.3 0.52 ± 0.2 0.48 ± 0.2
25-hydroxycholesterol 0.35 ± 0.3 0.38 ± 0.1 0.42 ± 0.2 0.43 ± 0.2 0.37 ± 0.1 0.40 ± 0.2
cholestan-3b,5a,6b-triol 10 ± 3 8.3 ± 2 8.5 ± 5 10.5 ± 4 9.4 ± 3 9.2 ± 3
total cholesterol 244 ± 57 203 ± 47* 191 ± 44* 227 ± 52 214 ± 53 224 ± 50
Values were corrected by 5-alpha cholestane (internal standard) and are expressed as ng/μg of cell protein ± DP (n = 12).
* p < 0.05 comparison were made between cells maintained in the presence of culture medium alone with HDL or HDL + T0901317. One way ANOVA and
Bonferroni post test (mean ± SD).
Figure 4 ABCA-1 protein level in control and glycolaldehyde-
treated macrophages. J774 macrophages were overloaded with
oxidized LDL (50 μg/mL de DMEM) for 48 h. In the last 5h, cells
were incubated with 0.25 mM glycolaldehyde (GAD; black bars) and
1 μM LXR agonist (T0901317). Control cells (C; gray bars) were
incubated with T0901317 alone. Cells were scrapped into TBS
containing protease inhibitors. Equal amounts of cell protein were
applied into a 6% polyacrylamide electrophoresis gel and
immunoblot was performed utilizing anti ABCA-1 antibody. Data
(arbitrary units; n = 4) were corrected per beta-actin.
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ketocholesterol, are related to cell toxicity and death by
inducing inflammation and endoplasmic reticulum stress
[14]. In fact, these oxysterols are prevalent in oxidized
LDL and its accumulation in arterial wall macrophages
is a hallmark of atherosclerosis and plaque instability
[15,16].
Oxidized LDL utilized to overload macrophages with
lipids previously to the incubation with HDL and LXR
agonist was in fact enriched in 7-ketocholesterol [17]
due to the no enzymatic conversion of cholesterol into
oxysterols. HDL on its turn presented very small
amounts of oxysterols maybe related to the acquisition
of these components from other lipoproteins before
plasma ultracentrifugation [18].
In cells grown in the absence of oxidized LDL only a
very small amount of oxysterols was detected by CG/MS
in regard to the total amount of cell cholesterol (data not
shown). Then, the majority of oxysterols that we found
in oxidized LDL-overloaded macrophages was originated
from the uptake of the modified LDL.
We found that advanced glycation in macrophages
induced by the treatment with glycolaldehyde disturbs
the exportation of 7-ketocholesterol, inducing its intra-
cellular accumulation. Interestingly, GAD treatment
mitigates the HDL ability to remove cell cholesterol and
7-ketocholesterol even in the presence of T0901317.
In cholesterol-enriched macrophages, ABCA-1 contri-
butes to a large amount of cholesterol net efflux to
lipid-poor apolipoprotein A-I generating pre- betaHDL.
In this present study a reduced amount of cellular
ABCA-1 protein level was observed in GAD-macro-
phages with a small increment in its expression even
after LXR agonist treatment.
We have recently demonstrated that advanced glycated
albumin isolated from poorly controlled diabetes melli-
tus’ serum reduces protein content of ABCA-1 and
ABCG-1 in macrophages, impairing cholesterol efflux
and inducing intracellular lipid accumulation [19]. It has
been previously shown that advanced glycation reduces
ABCG-1 mRNA levels by impairing ABCG-1 gene tran-
scriptional activity independently of LXR [6]. On the
other hand, advanced glycation induced both by oxoalde-
hyde or advanced glycated albumin treatment reduces
ABCA-1 protein levels in macrophages which are not
related to alterations in ABCA-1 mRNA levels [6,20].
The mechanisms that regulate ABCA-1 final protein con-
tent in cells submitted to advanced glycation are not
completely understood so far but may involve post-trans-
lational modifications of ABCA-1. Previous data from
our group showed that advanced glycated albumin
induces the expression of endoplasmic reticulum stress
and unfolded protein response markers in macrophages.
Interestingly, a chemical chaperone (4-phenylbutyric
acid) that alleviates endoplasmic reticulum stress is able
to recover ABCA-1 level and apo A-I- mediated choles-
terol efflux in these cells [14]. These events were also
related to the elevated generation of reactive oxygen spe-
cies in glycolaldehyde-modified albumin-treated macro-
phages, since treatment with aminoguanidine that
reduced ROS generation was able to restore ABCA-1
protein content [21]. AGE-albumin also primers macro-
phages to inflammation which is related to the dimin-
ished cholesterol exportation to apolipoprotein A-I [22].
Although we were not able to detect by immunoblot
CML derivatives in ABCA-1 and ABCG-1, at this point
we cannot completely exclude that part of the changes
observed in the content and activity of ABCA-1
and ABCG-1 relates to GAD modification of both
transporters.
Oxidative stress and inflammation induced by AGE
trigger endoplasmic reticulum stress that is also
observed in instable atherosclerotic plaques enriched in
7-ketocholesterol. More recently, Yehuda et al [23] have
demonstrated that a lipid extract obtained from carotid
atherosclerotic lesion induces the expression of inflam-
matory markers in macrophages, which was mainly
attributed to the cholesterol and oxysterol-enriched frac-
tion (7alpha-hydroxycholesterol, 7beta-hydroxycholes-
terol, 7-ketocholesterol and 26-hydroxycholesterol) of
the lipid extract.
Figure 5 ABCG-1 protein level in control and glycolaldehyde-
treated macrophages. J774 macrophages were overloaded with
oxidized LDL (50 μg/mL de DMEM) for 48 h. In the last 5h, cells
were incubated with 0.25 mM glycolaldehyde (GAD; black bars) and
1 μM LXR agonist (T0901317). Control cells (C; gray bars) were
incubated with T0901317 alone. Cells were scrapped into TBS
containing protease inhibitors. Equal amounts of cell protein were
applied into a 6% polyacrylamide electrophoresis gel and
immunoblot was performed utilizing anti ABCG-1 antibody. Data
(arbitrary units; n = 4) were corrected per beta-actin.
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terol to large HDL minimizing its apoptotic effects in
macrophages. Nonetheless, in ABCG-1 knockout mice the
development of atherosclerosis is still controversial. It is
possible that in those animal models the compensatory
expression of ABCA-1 may abrogates the absence of
ABCG-1-mediated lipid efflux. In the setting of hypergly-
cemia, AGE formation is prevalent compromising both
the expressions of ABCA-1 and ABCG-1. Then, the accu-
mulation of 7-ketocholesterol together with total sterols
may aggravate the development of atherosclerosis in dia-
betes mellitus.
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